Oklahoma Opioid Prescribing Guidelines

Opioid Prescribing Guidelines

The Oklahoma Hospital Association has endorsed the Best Practices Opioid Prescribing Guidelines that were developed by a multidisciplinary group of providers including the Oklahoma State Medical Association (OSMA); Oklahoma Hospital Association (OHA); Oklahoma Osteopathic Association (OOA); the executive staff of the Oklahoma State Medical Licensure Board; the executive staff of the Oklahoma State Board of Osteopathic Examiners; and many others. These guidelines succinctly describe the requirements for opioid prescribing that were developed by SB 1446 in the 2018 legislative session and SB 848 in the 2019 session.  

To download “Compliance and Best Practice for an Act Regulating the Use of Opioid Drugs – Oklahoma Senate Bills 1446 & 848,” click here.

Also available are two documents produced by OSMA: “Sample written policy for Physicians for the Qualifying Opioid Patient” and “Sample Opioid Therapy Patient-Provider Agreement.”

The “Best Practice” document represents our best efforts to describe the law on prescribing of opioids effective May 19, 2018. OHA has interpreted both SB 1466 and SB 848 to apply to all settings where a prescription is being filled at a retail pharmacy. If the patient is admitted and is only inpatient, SB 1466 and SB 848 does not apply under the language in the bill. Once the patient is discharged from acute care and is discharged as an outpatient, SB 1446 and SB 848 applies. For a bill summary of SB 848, click here.

Please note the exemptions from SB 1446 and SB 848 include patients who are receiving active treatment of cancer, in hospice, receiving palliative care, or residents of a long-term care facility. There are two sections of SB 1446 and SB 848 impacting minors – informed consent and Patient-Provider Agreements for pain management.

For more information and resources on the opioid crisis, click here.